MedTrace Logo

Lemon Verbena Extract Oxidative Stress and Muscle Damage

NCT04742244 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2021-03-10

No results posted yet for this study

Summary

In the present study, investigators investigated whether supplementation with lemon verbena extract (LVE) could improve muscle damage and biochemical indicators after exhaustive exercise challenge. Based on maximum jump heights, 60 subjects (30 males and 30 females) were equally divided into a placebo group (0 mg/human/day) and an LVE supplement group (400 mg/human/day), with gender-equal distribution. All subjects started supplementation 10 days before exhaustive exercise and continued it until all tests were completed. Before the intervention, after the exhaustive exercise, and on the following 3 days, the participants underwent 12-minute Cooper running/walking; blood collection; assessments of pain, muscle stiffness, maximum jump heights, and isometric maximum muscle strength; and anaerobic strength tests.

Conditions

  • Muscle Injury
  • Muscle Soreness

Interventions

DIETARY_SUPPLEMENT

Lvemon verbena extract

Each capsule contained 200 mg of lemon verbena extract 2 capsules/day, 14 days

DIETARY_SUPPLEMENT

maltodextrin

Each capsule contained 0 mg of lemon verbena extract 2 capsules/day, 14 days

Sponsors & Collaborators

  • National Taiwan Sport University

    lead OTHER

Principal Investigators

  • Chi-Chang Huang, Ph.D · PI

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-05-28
Primary Completion
2020-07-28
Completion
2020-08-13

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04742244 on ClinicalTrials.gov